Latest Regulatory Milestones News

Page 13 of 73
Vitrafy Life Sciences has marked significant progress in Q2 FY2026 with a strategic partnership, commercial launch in North America, and advancing clinical trials, underpinning its growth in cryopreservation technology.
Ada Torres
Ada Torres
29 Jan 2026
BPH Energy’s December quarter report reveals significant progress in its investee projects amid ongoing legal challenges and strategic capital management. The company balances judicial reviews, regulatory milestones, and funding plans across energy and medical technology sectors.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.
Ada Torres
Ada Torres
28 Jan 2026
Meteoric Resources has cleared a major regulatory hurdle with the approval of its Preliminary Environmental License for the Caldeira Rare Earths Project, enabling the company to progress towards construction and first production targeted for 2028. The company also commissioned its pilot plant, producing its first batches of rare earth carbonate.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Megado Minerals is poised to advance its Iberian Copper Project with investigation permits expected early 2026, setting the stage for airborne geophysics and maiden drilling. Meanwhile, the company maintains strong positions in Canadian lithium and gold assets.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Emerald Resources NL has announced a significant update to its Dingo Range Gold Project in Western Australia, increasing its mineral resource to 1.41 million ounces of gold and securing full mining permits ahead of planned development in 2026.
Maxwell Dee
Maxwell Dee
28 Jan 2026
EMVision Medical Devices reports strong clinical trial progress for its portable brain scanners, backed by solid cash reserves and milestone grant funding.
Ada Torres
Ada Torres
28 Jan 2026
Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.
Ada Torres
Ada Torres
28 Jan 2026
Javelin Minerals is advancing towards gold production at its Eureka Gold Project in Western Australia, targeting a June 2026 start under a new partnership with MEGA Resources. The company also identifies promising exploration targets at Coogee and maintains a solid cash position to support development.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Magnetic Resources NL has upgraded its Lady Julie Gold Project resource to 2.24 million ounces, with over 80% now in the Indicated category, positioning the company closer to development readiness. The LJN4 deposit remains a standout as one of Western Australia’s largest and highest-grade undeveloped open pit gold deposits.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.
Ada Torres
Ada Torres
27 Jan 2026
Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.
Ada Torres
Ada Torres
27 Jan 2026